Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-05-24

FDA Approved: ONDANSETRON — Supplemental Application (Accord Healthcare, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Ondansetron, manufactured by Accord Healthcare, Inc., signaling an update to its regulatory status for this generic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON)